Key Record Dates
ClinicalTrials.gov Identifier: | NCT04322188 |
---|---|
Brief Title: | An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications (SISCO) |
First Submitted : | March 24, 2020 |
First Submitted that Met QC Criteria : | March 25, 2020 |
First Posted : | March 26, 2020 |
Last Update Submitted that Met QC Criteria : | May 28, 2020 |
Last Update Posted : | June 1, 2020 |